Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/17677
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoss, J.-
dc.contributor.authorTeesson, M.-
dc.contributor.authorDarke, S.-
dc.contributor.authorLynskey, M.-
dc.contributor.authorAli, R.-
dc.contributor.authorRitter, A.-
dc.contributor.authorCooke, R.-
dc.date.issued2005-
dc.identifier.citationDrug and Alcohol Review, 2005; 24(5):411-418-
dc.identifier.issn0959-5236-
dc.identifier.issn1465-3362-
dc.identifier.urihttp://hdl.handle.net/2440/17677-
dc.description.abstractThe current study aimed to describe the characteristics (demographics, drug use, mental and physical health) of entrants to treatment for heroin dependence in three treatment modalities; and to compare these characteristics with heroin users not in or seeking treatment. Participants were 825 current heroin users recruited from Sydney, Adelaide and Melbourne: 277 entering methadone/buprenorphine maintenance treatment (MT), 288 entering detoxification (DTX), 180 entering drug-free residential rehabilitation (RR) and 80 not in treatment (NT). Treatment entrants were generally long-term heroin users with previous treatment experience. The majority of the sample (55%) were criminally active in the month preceding interview. Injection-related health problems (74%) and a history of heroin overdose (58%) were commonly reported. There were high degrees of psychiatric co-morbidity, with 49% reporting severe psychological distress, 28% having current major depression, 37% having attempted suicide and 42% having a lifetime history of post-traumatic stress disorder. Personality disorders were also prevalent, with 72% meeting criteria for antisocial personality disorder and 47% screening positive for borderline personality disorder. Striking similarities were noted between the non-treatment and treatment groups in length of heroin use career, drug use and treatment histories.-
dc.description.statementofresponsibilityRoss, Joanne ; Teesson, Maree ; Darke, Shane ; Lynskey, Michael ; Ali, Robert ; Ritter, Alison ; Cooke, Richard-
dc.language.isoen-
dc.publisherCarfax Publishing-
dc.source.urihttp://dx.doi.org/10.1080/09595230500286039-
dc.subjectHumans-
dc.subjectHeroin Dependence-
dc.subjectMethadone-
dc.subjectBuprenorphine-
dc.subjectNarcotics-
dc.subjectTreatment Outcome-
dc.subjectSeverity of Illness Index-
dc.subjectSuicide-
dc.subjectStress Disorders, Post-Traumatic-
dc.subjectDepressive Disorder, Major-
dc.subjectResidential Treatment-
dc.subjectComorbidity-
dc.subjectDemography-
dc.subjectHealth Status-
dc.subjectCrime-
dc.subjectDiagnostic and Statistical Manual of Mental Disorders-
dc.subjectAdult-
dc.subjectPatient Acceptance of Health Care-
dc.subjectAustralia-
dc.subjectFemale-
dc.subjectMale-
dc.subjectInactivation, Metabolic-
dc.titleThe characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)-
dc.typeJournal article-
dc.identifier.doi10.1080/09595230500286039-
pubs.publication-statusPublished-
dc.identifier.orcidAli, R. [0000-0003-2905-8153]-
Appears in Collections:Aurora harvest 2
Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.